Clinical Trial Update: Study to Evaluate the Effect of FX006 on Synovial Inflammation in Patients With OA of the Knee [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating FX006 for knee osteoarthritis has completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis Knee

Drugs mentioned

• FX006

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Osteoarthritis, Knee | Phase 3 | Status: COMPLETED | Results posted: 2020-12-08